Cargando…

Anti-sclerostin antibodies: a new frontier in fragility fractures treatment

Bone fragility is the determinant of the increased risk of minimal trauma fracture and must be treated with a multimodal approach that includes pharmacological therapy, physical exercise, and adequate nutrition. Pharmacological therapy, to date based on the administration of antiresorptive drugs, su...

Descripción completa

Detalles Bibliográficos
Autores principales: Iolascon, Giovanni, Liguori, Sara, Paoletta, Marco, Toro, Giuseppe, Moretti, Antimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10492476/
https://www.ncbi.nlm.nih.gov/pubmed/37694185
http://dx.doi.org/10.1177/1759720X231197094